miR-210 is a Serological Biomarker for Predicting Recurrence and Prognosis of Colon Carcinoma Patients with Liver Metastases After Radiofrequency Ablation Treatment

Zhang Y, Zhou YM, Zhang ZJ, Li X

Cancer Management and Research 2020, 12:9077-9085

Published Date: 25 September 2020